Double-blind, Placebo-controlled Study of BGC20-1531 in Migraine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00888680
Recruitment Status : Withdrawn (No patients enrolled. Delay due to optimisation of drug product formulation.)
First Posted : April 28, 2009
Last Update Posted : January 13, 2016
Information provided by (Responsible Party):
BTG International Inc.

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : No date given
  Study Completion Date : No date given